• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[贫血患者的输血。何时以及如何进行?]

[Blood transfusion in anemic patients. When and how?].

作者信息

Hervé P

机构信息

Centre régional de transfusion sanguine, Besançon.

出版信息

Rev Prat. 1993 Jun 1;43(11):1403-6.

PMID:8235391
Abstract

The functional red cells infused must breathe and circulate. The effectiveness of transfusion depends on different factors in patients (lack of antibodies or hypersplenism) and on the way the blood has been preserved. The transfusion-related risks may be immediate (immunological conflicts between erythrocytes or leucocytes) or delayed (alloimmunization induced by transfusion, transmission of or viral or parasitic diseases). The current preventive measures are highly efficient, provided all "safety catches" are respected, including selection of donors on immunological and serological grounds, and choice of the red cell concentrate most appropriate to the clinical situation and the transfusional future of the patient. All patients on chronic transfusion must be under long-term surveillance, with search for antibodies and serological profile. The decision to transfuse blood rests on the levels of erythrocyte constants and on clinical tolerance to anaemia, taking into account the compensatory mechanisms. Several formulas are available to calculate the red cell volume to be transfused in relation to haemoglobin values. The advances achieved in blood perfusion are such that anaemic patients nowadays are both less and better transfused.

摘要

输注的功能性红细胞必须能够呼吸和循环。输血的有效性取决于患者的不同因素(缺乏抗体或脾功能亢进)以及血液的保存方式。输血相关风险可能是即时的(红细胞或白细胞之间的免疫冲突)或延迟的(输血诱导的同种免疫、病毒或寄生虫疾病的传播)。当前的预防措施非常有效,前提是所有“安全措施”都得到遵守,包括基于免疫学和血清学标准选择献血者,以及选择最适合临床情况和患者输血前景的红细胞浓缩液。所有接受慢性输血的患者都必须接受长期监测,检测抗体和血清学特征。输血的决定取决于红细胞常数水平以及对贫血的临床耐受性,并考虑到代偿机制。有几种公式可用于根据血红蛋白值计算要输注的红细胞量。血液灌注方面取得的进展使得如今贫血患者的输血次数减少且输血效果更好。

相似文献

1
[Blood transfusion in anemic patients. When and how?].[贫血患者的输血。何时以及如何进行?]
Rev Prat. 1993 Jun 1;43(11):1403-6.
2
[Blood component therapy: differential indication for erythrocyte transfusion].[血液成分疗法:红细胞输血的不同适应证]
Infusionsther Klin Ernahr. 1980 Aug;7(4):184-9.
3
A preliminary study of placental umbilical cord whole blood transfusion in under resourced patients with malaria in the background of anaemia.在资源匮乏地区贫血背景下患疟疾患者中进行胎盘脐带全血输血的初步研究。
Malar J. 2006 Mar 23;5:20. doi: 10.1186/1475-2875-5-20.
4
Transfusion strategy.输血策略。
Eur J Anaesthesiol. 2001 Aug;18(8):495-8. doi: 10.1046/j.1365-2346.2001.00883.x.
5
Transfusional profile in different types of intensive care units.不同类型重症监护病房的输血情况
Braz J Anesthesiol. 2014 May-Jun;64(3):183-9. doi: 10.1016/j.bjane.2013.07.012. Epub 2014 Feb 14.
6
Transfusion therapy in critically ill children.危重症儿童的输血治疗
Pediatr Neonatol. 2008 Apr;49(2):5-12. doi: 10.1016/S1875-9572(08)60004-2.
7
Patient blood management.患者血液管理
Anesthesiology. 2012 Jun;116(6):1367-76. doi: 10.1097/ALN.0b013e318254d1a3.
8
Which carries the biggest risk: Anaemia or blood transfusion?贫血和输血,哪个风险更大?
Transfus Clin Biol. 2015 Aug;22(3):148-50. doi: 10.1016/j.tracli.2015.05.001. Epub 2015 Jun 9.
9
[Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].[马里巴马科的镰状细胞贫血与输血安全。镰状细胞贫血患者中HIV、HBV和HCV感染的血清流行率以及Rh和Kell系统的同种免疫]
Transfus Clin Biol. 2013 Dec;20(5-6):476-81. doi: 10.1016/j.tracli.2013.04.111. Epub 2013 Aug 2.
10
High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease.炎症性肠病患者输血诱导同种免疫的风险高。
Am J Med. 2012 Jul;125(7):717.e1-8. doi: 10.1016/j.amjmed.2011.11.028. Epub 2012 May 4.